NCT06587607

Brief Summary

This study involves delivering a mindfulness program that was developed for Veterans called VA Compassionate Awareness Learning Module (VA CALM) to Veterans with spinal cord injuries (SCI) to develop accommodations to make the VA CALM program more accessible for those with SCI. It will involve delivering the unmodified curriculum to a group of Veterans with SCI first to determine what areas need accommodations, working with a group of stakeholders to develop appropriate accommodations, and then delivering 1-2 modified modules via virtual reality to evaluate whether using virtual reality was feasible and acceptable for this program.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Jul 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Jul 2025Jun 2027

First Submitted

Initial submission to the registry

September 4, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

2 years

First QC Date

September 4, 2024

Last Update Submit

February 26, 2026

Conditions

Keywords

Spinal Cord InjuriesChronic PainVirtual RealityMindfulness

Outcome Measures

Primary Outcomes (6)

  • Mindfulness- Five Facet Mindfulness Questionnaire (FFMQ)

    Minimum Score: 1 Maximum Score: 5 Score Interpretation: Items are aggregated and averaged. Higher scores indicate greater mindfulness.

    Baseline to 2 weeks post completion (Approx 14 weeks).

  • Pain- PROMIS-Pain Numeric Rating Scale (NRS)

    Minimum Score: 0 Maximum Score: 10 Score Interpretation: Single item measure, higher scores indicate greater pain intensity.

    Baseline to 2 weeks post completion (Approx 14 weeks).

  • Mindfulness- Mindfulness Attention Awareness Scale (MAAS)

    Minimum Score: 1 Maximum Score: 6 Score Interpretation: Items are aggregated and averaged. Higher scores indicate greater mindfulness

    Baseline to 2 weeks post completion (Approx 14 weeks).

  • Pain Interference- PROMIS-Pain Interference (PROMIS-PI, SF8a)

    Minimum Score: 8 Maximum Score: 40 Score Interpretation: Scores are converted into a T-score which rescales the score into a standardized score with a mean of 50 and a standard deviation of 10. Higher scores indicate greater pain interference.

    Baseline to 2 weeks post completion (Approx 14 weeks).

  • Pain Acceptance- Chronic Pain Acceptance Questionnaire-Revised (CPAQ-R)

    Minimum Score: 0 Maximum Score: 6 Score Interpretation: Generates scores for two domains: Activity Engagement and Pain Willingness. Scores for each item in a domain are aggregated. Higher scores indicate higher levels of acceptance.

    Baseline to 2 weeks post completion (Approx 14 weeks).

  • Pain Catastrophizing- Pain Catastrophizing Scale (PCS)

    Minimum Score: 0 Maximum Score: 52 Score Interpretation: Generates a total score PCS-T and three subscale scores: Rumination, Magnification, and Helplessness. Total score above 30 indicates clinically relevant level of catastrophizing.

    Baseline to 2 weeks post completion (Approx 14 weeks).

Secondary Outcomes (9)

  • Quality of Life- World Health Organization Quality of Life-Brief (WHOQOL-BREF)

    Baseline to 2 weeks post completion (Approx 14 weeks).

  • Anxiety- Generalized Anxiety Disorder (GAD-7)

    Baseline to 2 weeks post completion (Approx 14 weeks).

  • Depression- Patient Health Questionnaire-9 (PHQ-9)

    Baseline to 2 weeks post completion (Approx 14 weeks).

  • Virtual Reality Embodiment- One-Item Presence Scale

    After completion of 2nd VR session (One time point at completion of study, approximately week 12).

  • Virtual Reality Embodiment- Virtual Embodiment Questionnaire

    After completion of 2nd VR session (One time point at completion of study, approximately week 12).

  • +4 more secondary outcomes

Study Arms (1)

VA CALM

EXPERIMENTAL

This group will receive the VA CALM mindfulness programming.

Behavioral: VA Compassionate Awareness Learning Module (VA CALM) a mindfulness curriculum.

Interventions

VA CALM is a 9 week mindfulness curriculum typically delivered at a once/week module pace in group settings during sessions that last approximately 60-90 minutes. Module topics include: Program Introduction, Why mindfulness, Perception, What Makes Something a Pleasant Experience?, Being Stuck, Getting Unstuck, Communication, Mindfulness in Daily Life, and Today is the First Dat of the Rest of Your Life.

Also known as: VA CALM
VA CALM

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran
  • Diagnosis of spinal cord injury with incomplete or complete tetraplegia based on AIS score OR incomplete or complete paraplegia based on AIS score.
  • Endorses chronic pain lasting 3 months;
  • age 18+ years
  • Access to high-speed internet
  • Endorse being (at least) minimally proficient on the computer (eg, able to check emails, read the news, etc.); be able, either independently or with caregiver support, to get online for virtual meetings and don/doff VR equipment
  • Able to speak clearly and independently to participate in focus group interviews.

You may not qualify if:

  • Individuals unable to consent for research or medical care are ineligible to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michael E. DeBakey VA Medical Center, Houston, TX

Houston, Texas, 77030-4211, United States

RECRUITING

MeSH Terms

Conditions

Spinal Cord InjuriesChronic Pain

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hilary Touchett, PhD MSN BSN

    Michael E. DeBakey VA Medical Center, Houston, TX

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hilary Touchett, PhD MSN BSN

CONTACT

Felicia Skelton, MD MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Single non-randomized group will be used to gather evaluation data on needed modifications to enhance program fit to the SCI population needs to develop a tailored curriculum for SCI. Outcomes will involve pre-post evaluation of measures to determine if there are any direct or indirect impacts of the mindfulness program as a preliminary feasibility study.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2024

First Posted

September 19, 2024

Study Start

July 1, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

March 2, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in articles to be published after de-identification (text, tables, figures, and appendices) as required by publishers, funding agencies, and or by law. Further, a Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 3 months and ending 36 months following article publication.
Access Criteria
Data sharing will be permitted for the purposes of validation of results via replication of analyses with the limited, de-identified database. Individually identifiable information will be removed from any database shared to ensure protection of personal privacy. Further the data will be shared pursuant to a data use agreement which prohibits re-identification.

Locations